Ted Buchan & Co
NVO icon

Ted Buchan & Co’s Novo Nordisk NVO Stock Holding History

Ted Buchan & Co’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.6M Sell
42,138
-19,160
-31% -$883K 0.53% 40
2026
Q2 		$2.94M Sell
61,298
-9,535
-13% -$410K 0.96% 26
2026
Q1 		$2.6M Buy
70,833
+32,294
+84% +$1.53M 0.95% 27
2025
Q4 		$1.96M Buy
38,539
+11,036
+40% +$564K 0.72% 32
2025
Q3 		$1.53M Buy
+27,503
New +$1.61M 0.6% 38

Other funds holding NVO

Everett Harris & Co
Everett Harris & Co Los Angeles, California $8.46B AUM 13.48% 1-Year Est. Return
Saratoga Research & Investment Management
Saratoga Research & Investment Management Saratoga, California $1.82B AUM 11.8% 1-Year Est. Return
Markel Group
Markel Group Glen Allen, Virginia $12.8B AUM 8.77% 1-Year Est. Return
Oppenheimer Asset Management
Oppenheimer Asset Management New York $9.5B AUM 23.46% 1-Year Est. Return
Euro Pacific Asset Management
Euro Pacific Asset Management Dorado, Puerto Rico $1.22B AUM 22.48% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Nichols & Pratt Advisers
Nichols & Pratt Advisers Boston, Massachusetts $1.68B AUM 20.22% 1-Year Est. Return
Corda Investment Management
Corda Investment Management Houston, Texas $1.52B AUM 30.53% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.16B AUM 31.35% 1-Year Est. Return

Ted Buchan & Co's NVO Position: Q3 2026 in Review

Ted Buchan & Co reduced its Novo Nordisk (NVO) stake by 31% in Q3 2026, selling an estimated $883K and leaving 42,138 shares worth $1.6M. The position accounts for 0.53% of the portfolio, ranked #40.

Ted Buchan & Co first reported a position in NVO in Q3 2025 and has held it in 5 quarters since. The position peaked at $2.94M in Q2 2026. 518 funds tracked by Wall St. Rank hold NVO as of Q3 2026.

  • Ted Buchan & Co held 42,138 shares of Novo Nordisk worth $1.6M as of Q3 2026.
  • Ted Buchan & Co sold 19,160 Novo Nordisk shares in Q3 2026, an estimated $883K.
  • Novo Nordisk made up 0.53% of Ted Buchan & Co's portfolio in Q3 2026, its #40 holding.
  • Ted Buchan & Co first reported a position in Novo Nordisk in Q3 2025 and has held it in 5 quarters since.
  • Ted Buchan & Co's Novo Nordisk position peaked at $2.94M in Q2 2026.
  • 518 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.

Based on Ted Buchan & Co's 13F filing for Q3 2026, filed 23 Oct 2026.